Literature DB >> 6606998

Magnesium enhances local anesthetic nerve block of frog sciatic nerve.

T Akutagawa, L M Kitahata, H Saito, J G Collins, J D Katz.   

Abstract

The present study was designed to examine the effects of increased magnesium concentration on the nerve block produced by lidocaine, benzocaine, and QX 572 (a quaternary derivative of lidocaine). Desheathed whole sciatic nerves from northern Rana pipiens frogs were placed in a sucrose gap chamber and stimulated at various frequencies at supramaximal intensity for the activation of the compound action potential. After control studies, the nerve was bathed by a calcium-free frog Ringer's solution containing magnesium concentrations of 3.0, 10.0, or 20.0 mM with or without 0.5 mM lidocaine, 0.5 mM benzocaine, or 0.75 mM QX 572. Compound action potentials were measured, and nonfrequency and frequency dependent blocks were compared in each solution. Increased magnesium ion concentration, in the absence of local anesthetics, enhanced the nonfrequency dependent block but did not change the frequency dependent block. All three local anesthetics enhanced both types of block. Increased magnesium concentrations enhanced only the nonfrequency dependent benzocaine block. In contrast, increased magnesium enhanced both types of block produced by QX 572 and lidocaine. These results suggest a potentially important interaction between high magnesium concentrations and local anesthetic nerve blocks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6606998

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  The effect of magnesium added to levobupivacaine for femoral nerve block on postoperative analgesia in patients undergoing ACL reconstruction.

Authors:  Perihan Ekmekci; Zuleyha Kazak Bengisun; Burak Akan; Baturay Kansu Kazbek; Kemal Sefa Ozkan; Arif Hikmet Suer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-14       Impact factor: 4.342

2.  Magnesium sulfate diminishes the effects of amide local anesthetics in rat sciatic-nerve block.

Authors:  Yu-Chun Hung; Chia-Ying Chen; Philipp Lirk; Chi-Fei Wang; Jen-Kun Cheng; Chien-Chuan Chen; Ging Kuo Wang; Peter Gerner
Journal:  Reg Anesth Pain Med       Date:  2007 Jul-Aug       Impact factor: 6.288

3.  Comparative efficacy of ropivacaine and levobupivacaine in combined femoral and lateral femoral cutaneous nerve block with adjuvant magnesium for post-operative analgesia.

Authors:  Prakash Khairnar; Munisha Agarwal; Uttam Chandra Verma; Rakesh Kumar
Journal:  Indian J Anaesth       Date:  2016-08

4.  Cold bupivacaine versus magnesium sulfate added to room temperature bupivacaine in sonar-guided femoral and sciatic nerve block in arthroscopic anterior cruciate ligament reconstruction surgery.

Authors:  Ashraf Elsayed Alzeftawy; Ahmad Ali El-Daba
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec

5.  Adding magnesium sulfate to bupivacaine in transversus abdominis plane block for laparoscopic cholecystectomy: A single blinded randomized controlled trial.

Authors:  K Al-Refaey; E M Usama; E Al-Hefnawey
Journal:  Saudi J Anaesth       Date:  2016 Apr-Jun

6.  A dose-finding randomised controlled trial of magnesium sulphate as an adjuvant in ultrasound-guided supraclavicular brachial plexus block.

Authors:  Versha Verma; Shelly Rana; Sudarshan Kumar Chaudhary; Jai Singh; Ravinder Kumar Verma; Saloni Sood
Journal:  Indian J Anaesth       Date:  2017-03

7.  Comparison of Magnesium Sulfate and Dexmedetomidine as an Adjuvant to 0.5% Ropivacaine in Infraclavicular Brachial Plexus Block.

Authors:  Mohamed M Abu Elyazed; Mona M Mogahed
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar

8.  Magnesium Sulfate as Adjuvant in Prehospital Femoral Nerve Block for a Patient with Diaphysial Femoral Fracture: A Randomized Controlled Trial.

Authors:  Chawki Jebali; Mohamed Kahloul; Nesrine Ibn Hassine; Mohamed Aymen Jaouadi; Fehmi Ferhi; Walid Naija; Naoufel Chebili
Journal:  Pain Res Manag       Date:  2018-12-03       Impact factor: 3.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.